{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:31:53Z","timestamp":1789403513195,"version":"build-2803163510"},"reference-count":11,"publisher":"Baishideng Publishing Group Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Methodol"],"abstract":"<jats:p>BACKGROUND<\/jats:p>\n                  <jats:p>Chronic nonspecific low back pain is defined as pain that persists for greater than 12 weeks and mainly occurs in the lower back with no evidence of associated underlying serious conditions [like malignancy, inflammation (like ankylosing spondylitis) or infection, vertebral fracture, etc. ].<\/jats:p>\n                  <jats:p>AIM<\/jats:p>\n                  <jats:p>To compare the efficacy and safety of amitriptyline with duloxetine in treating chronic low back pain (CLBP).<\/jats:p>\n                  <jats:p>METHODS<\/jats:p>\n                  <jats:p>The present study was a two-arm observational study conducted over 18 months in a tertiary rehabilitation setting. A total of 254 patients were included in the study.<\/jats:p>\n                  <jats:p>RESULTS<\/jats:p>\n                  <jats:p>The mean age was significantly higher in the amitriptyline group (34.78 \u00b1 8.22 years) compared with the duloxetine group (29.98 \u00b1 7.28 years, P  &lt; 0.0001). Baseline visual analog scale (VAS) scores were also significantly different between groups (amitriptyline: 7.92 \u00b1 0.56; duloxetine: 8.46 \u00b1 0.79; P  &lt; 0.0001). Within-group analysis showed a significant reduction in VAS scores over time in both groups (P  &lt; 0.001). At 12 weeks the duloxetine group showed significantly lower VAS scores (0.92 \u00b1 0.78) compared with the amitriptyline group (1.87 \u00b1 1.71; P  &lt; 0.0001). Analysis of variance, adjusting for age and baseline VAS, confirmed a significant group effect on pain reduction at 12 weeks (P  &lt; 0.001), favoring duloxetine. Side effects were generally mild. The most common in the amitriptyline group were dry mouth (17.3%) and drowsiness (7.9%) while in the duloxetine group, dry mouth (15.7%) and constipation (2.4%) were most reported.<\/jats:p>\n                  <jats:p>CONCLUSION<\/jats:p>\n                  <jats:p>Amitriptyline and duloxetine effectively treat CLBP; however, considering side effects and more sustained pain relief, duloxetine appears to be the better option. Nonetheless, treatment choice should consider individual patient profiles.<\/jats:p>","DOI":"10.5662\/wjm.v16.i1.107203","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T02:00:05Z","timestamp":1770688805000},"source":"Crossref","is-referenced-by-count":2,"title":["Comparative effectiveness of amitriptyline\n                    <i>vs<\/i>\n                    duloxetine in the treatment of chronic low back pain: An observational study"],"prefix":"10.5662","volume":"16","author":[{"given":"Nityananda","family":"Sardar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raktim","family":"Swarnakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumyadipta","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj Kumar","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"B1","unstructured":"Maharty DC, Hines SC, Brown RB. Chronic Low Back Pain in Adults: Evaluation and Management. Am Fam Physician 2024; 233-244"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-020-00137-5"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204428"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.3445"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-010-1502-y"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014682.pub2"},{"key":"B7","doi-asserted-by":"crossref","unstructured":"Chung JW, Zeng Y, Wong TK. Drug therapy for the treatment of chronic nonspecific low back pain: systematic review and meta-analysis. Pain Physician 2013; E685-E704","DOI":"10.36076\/ppj.2013\/16\/E685"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j603"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.4222"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15169"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/17581869.2024.2408215"}],"container-title":["World Journal of Methodology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2222-0682\/full\/v16\/i1\/107203.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/2222-0682\/full\/v16\/i1\/107203.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T02:00:27Z","timestamp":1770688827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2222-0682\/full\/v16\/i1\/107203.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":11,"journal-issue":{"issue":"1"},"alternative-id":["107203"],"URL":"https:\/\/doi.org\/10.5662\/wjm.v16.i1.107203","relation":{},"ISSN":["2222-0682"],"issn-type":[{"value":"2222-0682","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,20]]}}}